Chemical Compound
2-Oxazolidinone, 4-[[3-[2-(dimethyloxidoamino)ethyl]-1H-indol-5-yl]methyl]-, (4S)-; (4S)-4-[[3-[2-(Dimethyloxidoamino)ethyl]-1H-indol-5-yl]methyl]-2-oxazolidinone; Zolmitriptan N-Oxide; Imp. B (EP); Zolmitriptan Related Compound E; Zolmitriptan Impurity B
CAS Registry Number
251451-30-6
Primary record
2-Oxazolidinone, 4-[[3-[2-(dimethyloxidoamino)ethyl]-1H-indol-5-yl]methyl]-, (4S)-; (4S)-4-[[3-[2-(Dimethyloxidoamino)ethyl]-1H-indol-5-yl]methyl]-2-oxazolidinone; Zolmitriptan N-Oxide; Imp. B (EP); Zolmitriptan Related Compound E; Zolmitriptan Impurity B
- 库存
- 9,114 克
- 纯度
- 98.6 %
- CAS
- 251451-30-6
化合物标识与属性
- CAS
- 251451-30-6
- PubChem CID
- 25241756
- SMILES
- C[N+](C)(CCC1=CNC2=C1C=C(C=C2)C[C@H]3COC(=O)N3)[O-]
- Canonical SMILES
- C[N+](C)([O-])CCc1c[nH]c2ccc(C[C@H]3COC(=O)N3)cc12
名称与同义词
- Zolmitriptan N-Oxide
- Zolmitriptan Impurity 2
- UNII-22Y9Y8XC4U
- RefChem:196227
- 22Y9Y8XC4U
- Zolmitriptan Related Compound E
- Zolmitriptan EP Impurity B
- 251451-30-6
- DTXCID60389166
- DTXSID00438344
- Zolmitriptan USP Related Compound E
- ZINC22067504
- 1652W92
- AKOS022182246
- ZOLMITRIPTAN IMPURITY B [EP IMPURITY]
- ZOLMITRIPTAN RELATED COMPOUND E [USP-RS]
- CS-0214531
- NS00116779
- ZOLMITRIPTAN IMPURITY B (EP IMPURITY)
- J1.179.582J
- ZOLMITRIPTAN RELATED COMPOUND E (USP-RS)
- ZOLMITRIPTAN RELATED COMPOUND E [USP IMPURITY]
- 2-Oxazolidinone, 4-((3-(2-(dimethyloxidoamino)ethyl)-1H-indol-5-yl)methyl)-, (4S)-
- Q27253688
- ZOLMITRIPTAN RELATED COMPOUND E (USP IMPURITY)
- N0001-010676
- 2-Oxazolidinone, 4-[[3-[2-(dimethyloxidoamino)ethyl]-1H-indol-5-yl]methyl]-, (4S)-
- (4S)-4-[[3-[2-(Dimethyloxidoamino)ethyl]-1H-indol-5-yl]methyl-2-oxazolidinone
- (S)-N,N-Dimethyl-2-(5-((2-oxooxazolidin-4-yl)methyl)-1H-indol-3-yl)ethanamine oxide
- Dimethyl[2-[5-[(2-oxooxazolidine-4beta-yl)methyl]-1H-indole-3-yl]ethyl](oxylato) ammonium
- N,N-dimethyl-2-[5-[(2-oxo-1,3-oxazolidin-4-yl)methyl]-1H-indol-3-yl]ethanamine Oxide
- N,N-Dimethyl-2-[5-[[(4S)-2-oxooxazolidine-4-yl]methyl]-1H-indole-3-yl]ethanamine N-oxide
- N,N-Dimethyl-5-[[(4S)-2-oxooxazolidine-4beta-yl]methyl]-1H-indole-3-ethanamine oxide
- (4S)-4-[[3-[2-(Dimethyloxidoamino)ethyl]-1H-indol-5-yl]methyl]-2-oxazolidinone, (S)-N,N-Dimethyl-2-{5-[(2-oxooxazolidin-4-yl)methyl]-1H-indol-3-yl}ethanamine oxide
- 2-Oxazolidinone, 4-[[3-[2-(dimethyloxidoamino)ethyl]-1H-indol-5-yl]methyl]-, (4S)-; (4S)-4-[[3-[2-(Dimethyloxidoamino)ethyl]-1H-indol-5-yl]methyl]-2-oxazolidinone; Zolmitriptan N-Oxide; Imp. B (EP); Zolmitriptan Related Compound E; Zolmitriptan Impurity B
- N,N-DIMETHYL-2-(5-{[(4S)-2-OXO-1,3-OXAZOLIDIN-4-YL]METHYL}-1H-INDOL-3-YL)ETHANAMINE OXIDE
- N,N-dimethyl-2-[5-[[(4S)-2-oxo-1,3-oxazolidin-4-yl]methyl]-1H-indol-3-yl]ethanamine oxide
- N/A